ATTGENO AB
556692-7751ActiveDeveloping targeted nitric oxide delivery drugs for critical care applications.
Oversigt
- 1–4
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2005
- Grundlagt
Beskrivelse
Attgeno is a Swedish biotechnology company focused on saving patient lives through advanced drug delivery systems. Their core mission revolves around the targeted delivery of nitric oxide (NO), a vital molecule in various physiological processes. The company is pioneering the third generation of NO...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556692775101
Beslutningstagere
Ingen beslutningstagere fundet endnu
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrCereno Scientific AB
10–19 medarbejderePioneering disease-modifying treatments for rare cardiovascular and pulmonary diseases.
LobSor Pharmaceuticals Aktiebolag
1–4 medarbejdereDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
MucoLife Therapeutics AB
1–4 medarbejdereDeveloping novel mucus modulators to treat COPD and Cystic Fibrosis.
Sangair AB
5–9 medarbejdereDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Omnio Healer AB
0 medarbejdereDeveloping regenerative plasminogen therapy to heal chronic wounds effectively.
Udforsk mere
Spørgsmål om ATTGENO AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo